共 177 条
[1]
Burris HA(1997)Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial J Clin Oncol 15 2403-2413
[2]
Moore MJ(1999)Randomized phase II trial of dose intense gemcitabine by standard infusion vs. fixed dose rate in metastatic pancreatic adenocarcinoma [abstract] Proc ASCO 18 273a-273a
[3]
Andersen J(2002)Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU)with PVI 5-FU plus mitomycin in inoperable pancreatic cancer J Clin Oncol 20 3130-3136
[4]
Tempero M(2002)A randomized trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma Ann Oncol 13 1185-1191
[5]
Plunkett W(2002)Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer J Clin Oncol 20 160-164
[6]
Ruiz van Haperen V(2002)A phase II and pharmacokinetic trial of S-1 in paitents with advanced pancreatic cancer (APC) [abstract] Proc ASCO 21 682a-682a
[7]
Maisey N(2000)Phase II study of the multitargeted antifolate LY 231514 (Alimta, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer Ann Oncol 11 101-103
[8]
Chau I(2002)A phase II/III trial of efficacy and tolerability of ZD9331 vs gemcitabine in pancreatic cancer [abstract] Proc ASCO 21 144a-144a
[9]
Cunningham D(1999)A phase II trial of Caelyx (liposomal doxorubicin, Doxil) in the treatment of advanced pancreatic carcinoma [abstract] Proc ASCO 18 306a-306a
[10]
Ducreux M(1985)Phase II study of epirubicin in advanced adenocarcinoma of the pancreas Eur J Cancer Clin Oncol 21 191-194